Supportive Care in Cancer

, Volume 7, Issue 6, pp 379–385

Psychopharmacology in supportive care in cancer: a review for the clinician

I. Benzodiazepines

Authors

  • F. Stiefel
    • Service de Psychiatrie de Liaison, CHUV, CH-1011 Lausanne, Switzerland Tel.: +41-21-141090, Fax +41-21-3141098
  • A. Berney
    • Service de Psychiatrie de Liaison, CHUV, CH-1011 Lausanne, Switzerland Tel.: +41-21-141090, Fax +41-21-3141098
  • C. Mazzocato
    • Unité de Soins Palliatifs, Centre Hospitalier Universitaire Vaudoise, Lausanne, Switzerland
SPECIAL ARTICLE

DOI: 10.1007/s005200050296

Cite this article as:
Stiefel, F., Berney, A. & Mazzocato, C. Support Care Cancer (1999) 7: 379. doi:10.1007/s005200050296

Abstract

 Benzodiazepines are widely utilized in the cancer setting. Most aspects relevant to their use in supportive care are reviewed to assist the clinical oncologist in prescribing such drugs. This review covers pharmacokinetics, indications, adverse effects and drug interactions, and compares the profiles of different benzodiazepines. Finally, controversial issues with regard to benzodiazepines are discussed.

Key words Benzodiazepines Cancer Palliative care Supportive care Review

Copyright information

© Springer-Verlag Berlin Heidelberg 1999